Core SmPC/PL

(see also Post referral Phase)

In order to view some of the documents on this website you need Acrobat Reader
(click here to download)

• Fludeoxyglucose (18F) - Revised Core SmPC and PL (December 2010)

• Hormone Replacement Therapy - Core Package Leaflet (March 2017) [Track version]
• Hormone Replacement Therapy - Core SmPC (March 2017) [Track version]
  
  PRAC recommendation on safety signal related to HRT products adopted at the PRAC meeting of 30 November - 3 December 2015  (please see EMA's website)

• Hormone Replacement Therapy - MRFG-PhVWP agreed updated core SmPC (October 2002)

• Hormone Replacement Therapy - SmPC wording for medicinal products used in HRT with regard to increased risk of venous thromboembolism as agreed by the PhVWP (September 2001)

• Hormone Replacement Therapy - SmPC wording for medicinal products used in HRT with regard to increased risk of breast cancer as agreed by the PhVWP (July 2001)

• EMA Explanatory Note on the withdrawal of the note for guidance on harmonisation of requirements for influenza vaccines